The National Institutes of Health's initial trial found the experimental vaccine for the Ebola virus so far is safe for humans and produced an immune response. Researches found anti-Ebola ...

Study collaborators at the NIH's National Institute of Allergy and Infectious Diseases (NIAID) found that treatment with mAb 3A6 can benefit non-human primates in advanced stages of Ebola virus ...

Study collaborators at the NIH's National Institute of Allergy and Infectious Diseases (NIAID) found that treatment with mAb 3A6 can benefit non-human primates in advanced stages of Ebola virus ...

MOSCOW, October 13. /TASS/. The second stage of the Russian Ebola vaccine trials will be completed by the end of the year, the head of the consumer watchdog, Rospotrebnadzor, said on Tuesday.

Ebola scare in Manhattan after two patients at ... These are often referred to as 'dry' symptoms. Mid-To-Late Stage Of The Disease Patients may develop gastrointestinal issues four to five days ...

Study collaborators at the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) found that treatment with mAb 3A6 can benefit non-human primates in advanced stages of Ebola virus ...